My last visits

BRAIN BIOTECH AG EUR BNN Stock
Log in
Log in
Or log in with
GoogleGoogle
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Apple Apple     
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. BRAIN Biotech AG
  6. Summary
    BNN   DE0005203947

BRAIN BIOTECH AG

(BNN)
  Report
Real-time Estimate Tradegate  -  11:36:00 2023-06-13 am EDT
4.770 EUR   +0.63%
05/25BRAIN Biotech AG Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023
CI
05/25BRAIN Biotech AG stays on solid growth path with H1 results and accelerates One-BioProducts strategy
EQ
05/24BRAIN Biotech to Look Acquisitions
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed Xetra
06/07/2023 06/08/2023 06/09/2023 06/12/2023 06/13/2023 Date
4.74(c) 4.8(c) 4.68(c) 4.74(c) 4.8 Last
8 244 4 547 8 919 777 3 939 Volume
0.00% +1.27% -2.50% +1.28% +1.27% Change
More quotes
Estimated financial data (e)
Sales 2023 57,0 M 61,2 M 61,2 M
Net income 2023 -5,85 M -6,29 M -6,29 M
Net Debt 2023 21,1 M 22,7 M 22,7 M
P/E ratio 2023 -22,4x
Yield 2023 -
Sales 2024 67,1 M 72,2 M 72,2 M
Net income 2024 -1,98 M -2,13 M -2,13 M
Net Debt 2024 23,4 M 25,2 M 25,2 M
P/E ratio 2024 -75,3x
Yield 2024 -
Capitalization 104 M 111 M 111 M
EV / Sales 2023 2,19x
EV / Sales 2024 1,89x
Nbr of Employees 318
Free-Float 42,6%
More Financials
Company
BRAIN Biotech AG, formerly known as BRAIN Biotechnology Research and Information Network AG is a Germany-based industrial biotechnology company develops and brings to market biological ingredients for Nutrition & Health, SkinCare and Industrial BioSolutions. Research & Development activities focus on bioactive natural compounds, tailored enzymes and high-performance microorganisms. 
Read more
More about the company
Ratings of BRAIN Biotech AG
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about BRAIN BIOTECH AG
05/25BRAIN Biotech AG Reports Earnings Results for the Second Quarter and Six Months Ended M..
CI
05/25BRAIN Biotech AG stays on solid growth path with H1 results and accelerates One-BioProd..
EQ
05/24BRAIN Biotech to Look Acquisitions
CI
05/24BRAIN Biotech AG gains full ownership of Biocatalysts Ltd and accelerates execution of ..
EQ
05/24BRAIN Biotech AG acquired remaining 17.8% stake in Biocatalysts Limited.
CI
05/17Afr : BRAIN Biotech AG: Preliminary announcement of the publication of financial reports a..
EQ
04/20Dd : BRAIN Biotech AG: Dr. Michael Majerus, buy
EQ
03/28SolasCure announces final closing of GBP 10.9m Series B fundraise to advance wound care..
AQ
03/27SolasCure Limited announced that it has received £10.9 million in funding from Seneca P..
CI
03/08Resolutions of the Annual General Meeting 2023 on the Financial Year 2021/2022 of BRAIN..
EQ
02/27BRAIN Biotech AG Reports Earnings Results for the First Quarter Ended December 31, 2022
CI
02/27Capital Markets Day 2023 : BRAIN Biotech AG to build an international multi-niche enzyme a..
EQ
02/27BRAIN Biotech AG with Strong Start into Fiscal Year 2022/23, 3M Reporting
EQ
02/22BRAIN Biotech and TransCode Therapeutics join forces to develop a CRISPR-derived techno..
EQ
02/10BRAIN Biotech Ends Contract with Roquette Frères on Natural Sweetener Joint Development
MT
More news
News in other languages on BRAIN BIOTECH AG
05/25BRAIN Biotech AG annonce ses résultats pour le deuxième trimestre et le semestre clos l..
05/25BRAIN Biotech AG bleibt mit Halbjahresergebnissen auf solidem Wachstumskurs und forcier..
05/25BRAIN Biotech AG bleibt mit Halbjahresergebnissen auf solidem Wachstumskurs und forcier..
05/24BRAIN Biotech cherche à faire des acquisitions
05/24BRAIN Biotech AG übernimmt Biocatalysts Ltd vollständig und beschleunigt die Umsetzung ..
More news
Analyst Recommendations on BRAIN BIOTECH AG
More recommendations
Chart BRAIN BIOTECH AG
Duration : Period :
BRAIN Biotech AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BRAIN BIOTECH AG
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 4,74 €
Average target price 12,23 €
Spread / Average Target 158%
EPS Revisions
Managers and Directors
Adriaan Moelker Chief Executive Officer
Michael Schneiders Chief Financial Officer
Michael Majerus Chairman
Alexander Pelzer Head-Research & Development
Anna Carina Eichhorn Deputy Chairman-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
BRAIN BIOTECH AG-18.84%111
WASTE MANAGEMENT3.84%66 275
REPUBLIC SERVICES, INC.11.46%45 472
WASTE CONNECTIONS, INC.2.39%34 950
GFL ENVIRONMENTAL INC.28.00%13 978
CLEAN HARBORS, INC.38.12%8 528
Secure and increase the performance of your investments with our team of experts at your side.
Securing my Investments
fermer